Agilent Granted Motion to Amend Complaint for Lawsuit Against Twist Bioscience

Dec 10, 2018

|

NEW YORK (GenomeWeb) – Agilent Technologies' motion to amend its complaint in a lawsuit it filed against Twist Bioscience in 2016 was granted, according to documents Twist filed today with the US Securities and Exchange Commission.

The Santa Clara Superior Court also denied Agilent's motion to limit the discovery that Twist and Twist CEO Emily Leproust could seek in the case and set a date for the trial of Feb. 24, 2020.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Australia's Gene Editing Policy Approach

Australia will not be regulating gene editing of plants, animals, and human cell lines as long as no new genetic material is incorporated, reports Nature News.

Just "Preliminary" Work

The Washington Post reports that the US Department of Agriculture told its researchers to label peer-reviewed articles as "preliminary" work.

Some Big Trees

Researchers have sequenced the genomes of both the coast redwood and the giant sequoia, according to the San Francisco Chronicle.

This Week in PNAS

In PNAS this week: study of epigenetic patterns in mammalian eggs, clonal expansion patterns in CD8+ T cells, and more.

Menu